Autopsy report · NCT00776659
An Observational Study Of Indian Breast Cancer Patients Receiving Adjuvant Therapy With Aromasin
Cause of deathNo reason given
“See termination reason in detailed description.”
Life of this trial
- Registered 2 months before it started.
- Ran for about 3 years 9 months before it stopped.
- 39 participants enrolled.
- Results were posted on the registry 1 year 2 months after it ended.
Vital statistics
- Status
- Terminated
- Sponsor
- Pfizer
- Sponsor type
- Industry
- Conditions
- Breast Neoplasms
- Interventions
- Aromasin
- Participants
- 39
- Sites
- 4
- Countries
- India
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.